Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents

Paul Brown, G. T. Krishnamurthy, V. R. Bobba, E. Kingston, F. E. Turner

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The radiation absorbed doses from five commercially available hepatobiliary agents - Tc-99m-tagged analogs of IDA (EIDA, PIPIDA, HIDA, PBIDA, DISIA) have been calculated from biokinetic data in 41 normal subjects. Serial gamma images, with blood and urine samples, were obtained to calculate cumulated radioactivity in the source organs: blood, kidney, bladder, liver, gallbladder, and intestines. The critical organ was the gallbladder, with an absorbed-dose range of 690 to 780 mrad/mCi. Absorbed doses for other target organs were: upper large intestine 320 to 370 mrad/mCi, lower large intestine 210 to 240, small intestine 170 to 200, liver 65 (DISIDA) to 130 (PBIDA), ovaries 63 to 72, and urinary bladder wall 23 (PBIDA) to 36 (EIDA). The radiation absorbed dose was largely independent of changes in chemical structure except in (a) the liver, where absorbed dose varied by a factor of two in proportion to the rate of excretion of the IDA agent from the liver, and (b) the urinary bladder, where absorbed dose varied by a factor of 1.6 because of differences in rate of excretion. When the stimulus for gallbladder emptying is changed from whole-meal ingestion to cholecystokinin injection, the absorbed dose to the gallbladder increases to ~1 rad/mCi; if no gallbladder emptying is assumed, its absorbed dose increases to ~1.9 rad/mCi. In the absence of contraindication, the gallbladder absorbed dose may thus be decreased by inducing gallbladder emptying at the end of the imaging study.

Original languageEnglish (US)
Pages (from-to)1025-1030
Number of pages6
JournalJournal of Nuclear Medicine
Volume23
Issue number11
StatePublished - 1982

Fingerprint

Gallbladder Emptying
Gallbladder
Radiation
Urinary Bladder
Liver
Large Intestine
Cholecystokinin
Radioactivity
Small Intestine
Intestines
Meals
Ovary
Eating
Urine
Kidney
Injections
technetium Tc 99m iminodiacetic acid

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Brown, P., Krishnamurthy, G. T., Bobba, V. R., Kingston, E., & Turner, F. E. (1982). Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents. Journal of Nuclear Medicine, 23(11), 1025-1030.

Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents. / Brown, Paul; Krishnamurthy, G. T.; Bobba, V. R.; Kingston, E.; Turner, F. E.

In: Journal of Nuclear Medicine, Vol. 23, No. 11, 1982, p. 1025-1030.

Research output: Contribution to journalArticle

Brown, P, Krishnamurthy, GT, Bobba, VR, Kingston, E & Turner, FE 1982, 'Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents', Journal of Nuclear Medicine, vol. 23, no. 11, pp. 1025-1030.
Brown P, Krishnamurthy GT, Bobba VR, Kingston E, Turner FE. Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents. Journal of Nuclear Medicine. 1982;23(11):1025-1030.
Brown, Paul ; Krishnamurthy, G. T. ; Bobba, V. R. ; Kingston, E. ; Turner, F. E. / Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents. In: Journal of Nuclear Medicine. 1982 ; Vol. 23, No. 11. pp. 1025-1030.
@article{23ed0549ff934cd3bf289c47b5c2168e,
title = "Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents",
abstract = "The radiation absorbed doses from five commercially available hepatobiliary agents - Tc-99m-tagged analogs of IDA (EIDA, PIPIDA, HIDA, PBIDA, DISIA) have been calculated from biokinetic data in 41 normal subjects. Serial gamma images, with blood and urine samples, were obtained to calculate cumulated radioactivity in the source organs: blood, kidney, bladder, liver, gallbladder, and intestines. The critical organ was the gallbladder, with an absorbed-dose range of 690 to 780 mrad/mCi. Absorbed doses for other target organs were: upper large intestine 320 to 370 mrad/mCi, lower large intestine 210 to 240, small intestine 170 to 200, liver 65 (DISIDA) to 130 (PBIDA), ovaries 63 to 72, and urinary bladder wall 23 (PBIDA) to 36 (EIDA). The radiation absorbed dose was largely independent of changes in chemical structure except in (a) the liver, where absorbed dose varied by a factor of two in proportion to the rate of excretion of the IDA agent from the liver, and (b) the urinary bladder, where absorbed dose varied by a factor of 1.6 because of differences in rate of excretion. When the stimulus for gallbladder emptying is changed from whole-meal ingestion to cholecystokinin injection, the absorbed dose to the gallbladder increases to ~1 rad/mCi; if no gallbladder emptying is assumed, its absorbed dose increases to ~1.9 rad/mCi. In the absence of contraindication, the gallbladder absorbed dose may thus be decreased by inducing gallbladder emptying at the end of the imaging study.",
author = "Paul Brown and Krishnamurthy, {G. T.} and Bobba, {V. R.} and E. Kingston and Turner, {F. E.}",
year = "1982",
language = "English (US)",
volume = "23",
pages = "1025--1030",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "11",

}

TY - JOUR

T1 - Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents

AU - Brown, Paul

AU - Krishnamurthy, G. T.

AU - Bobba, V. R.

AU - Kingston, E.

AU - Turner, F. E.

PY - 1982

Y1 - 1982

N2 - The radiation absorbed doses from five commercially available hepatobiliary agents - Tc-99m-tagged analogs of IDA (EIDA, PIPIDA, HIDA, PBIDA, DISIA) have been calculated from biokinetic data in 41 normal subjects. Serial gamma images, with blood and urine samples, were obtained to calculate cumulated radioactivity in the source organs: blood, kidney, bladder, liver, gallbladder, and intestines. The critical organ was the gallbladder, with an absorbed-dose range of 690 to 780 mrad/mCi. Absorbed doses for other target organs were: upper large intestine 320 to 370 mrad/mCi, lower large intestine 210 to 240, small intestine 170 to 200, liver 65 (DISIDA) to 130 (PBIDA), ovaries 63 to 72, and urinary bladder wall 23 (PBIDA) to 36 (EIDA). The radiation absorbed dose was largely independent of changes in chemical structure except in (a) the liver, where absorbed dose varied by a factor of two in proportion to the rate of excretion of the IDA agent from the liver, and (b) the urinary bladder, where absorbed dose varied by a factor of 1.6 because of differences in rate of excretion. When the stimulus for gallbladder emptying is changed from whole-meal ingestion to cholecystokinin injection, the absorbed dose to the gallbladder increases to ~1 rad/mCi; if no gallbladder emptying is assumed, its absorbed dose increases to ~1.9 rad/mCi. In the absence of contraindication, the gallbladder absorbed dose may thus be decreased by inducing gallbladder emptying at the end of the imaging study.

AB - The radiation absorbed doses from five commercially available hepatobiliary agents - Tc-99m-tagged analogs of IDA (EIDA, PIPIDA, HIDA, PBIDA, DISIA) have been calculated from biokinetic data in 41 normal subjects. Serial gamma images, with blood and urine samples, were obtained to calculate cumulated radioactivity in the source organs: blood, kidney, bladder, liver, gallbladder, and intestines. The critical organ was the gallbladder, with an absorbed-dose range of 690 to 780 mrad/mCi. Absorbed doses for other target organs were: upper large intestine 320 to 370 mrad/mCi, lower large intestine 210 to 240, small intestine 170 to 200, liver 65 (DISIDA) to 130 (PBIDA), ovaries 63 to 72, and urinary bladder wall 23 (PBIDA) to 36 (EIDA). The radiation absorbed dose was largely independent of changes in chemical structure except in (a) the liver, where absorbed dose varied by a factor of two in proportion to the rate of excretion of the IDA agent from the liver, and (b) the urinary bladder, where absorbed dose varied by a factor of 1.6 because of differences in rate of excretion. When the stimulus for gallbladder emptying is changed from whole-meal ingestion to cholecystokinin injection, the absorbed dose to the gallbladder increases to ~1 rad/mCi; if no gallbladder emptying is assumed, its absorbed dose increases to ~1.9 rad/mCi. In the absence of contraindication, the gallbladder absorbed dose may thus be decreased by inducing gallbladder emptying at the end of the imaging study.

UR - http://www.scopus.com/inward/record.url?scp=0020438632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020438632&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 1025

EP - 1030

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 11

ER -